Tags

Type your tag names separated by a space and hit enter

Psychopharmacologic treatment of depression.
Psychiatr Clin North Am. 1984 Sep; 7(3):503-17.PC

Abstract

The authors emphasize the favorable response of most patients with major depression to appropriate pharmacotherapy, and present a decision-tree approach to the pharmacotherapy of major depression. Also discussed are use of contemporary clinical nosology and neuroendocrine diagnostic tests to identify candidates for pharmacotherapy and/or ECT, use of secondary tricyclics because of their lower incidence of side-effects, monitoring plasma levels of antidepressants to achieve therapeutic levels, and potentiating tricyclic nonresponders with T3 or lithium.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

6148743

Citation

Extein, I, et al. "Psychopharmacologic Treatment of Depression." The Psychiatric Clinics of North America, vol. 7, no. 3, 1984, pp. 503-17.
Extein I, Gold MS, Pottash AL. Psychopharmacologic treatment of depression. Psychiatr Clin North Am. 1984;7(3):503-17.
Extein, I., Gold, M. S., & Pottash, A. L. (1984). Psychopharmacologic treatment of depression. The Psychiatric Clinics of North America, 7(3), 503-17.
Extein I, Gold MS, Pottash AL. Psychopharmacologic Treatment of Depression. Psychiatr Clin North Am. 1984;7(3):503-17. PubMed PMID: 6148743.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Psychopharmacologic treatment of depression. AU - Extein,I, AU - Gold,M S, AU - Pottash,A L, PY - 1984/9/1/pubmed PY - 1984/9/1/medline PY - 1984/9/1/entrez SP - 503 EP - 17 JF - The Psychiatric clinics of North America JO - Psychiatr. Clin. North Am. VL - 7 IS - 3 N2 - The authors emphasize the favorable response of most patients with major depression to appropriate pharmacotherapy, and present a decision-tree approach to the pharmacotherapy of major depression. Also discussed are use of contemporary clinical nosology and neuroendocrine diagnostic tests to identify candidates for pharmacotherapy and/or ECT, use of secondary tricyclics because of their lower incidence of side-effects, monitoring plasma levels of antidepressants to achieve therapeutic levels, and potentiating tricyclic nonresponders with T3 or lithium. SN - 0193-953X UR - https://www.unboundmedicine.com/medline/citation/6148743/Psychopharmacologic_treatment_of_depression_ L2 - http://www.diseaseinfosearch.org/result/2199 DB - PRIME DP - Unbound Medicine ER -